Kastrati A - Search Results

1

Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis.

Stettler C, Allemann S, Wandel S, Kastrati A, Morice MC, Schömig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabaté M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, De Carlo M, Erglis A, Chechi T, Ortolani P, Schalij MJ, Diem P, Meier B, Windecker S, Jüni P. Stettler C, et al. Among authors: kastrati a. BMJ. 2008 Aug 29;337:a1331. doi: 10.1136/bmj.a1331. BMJ. 2008. PMID: 18757996 Free PMC article. Review.

2

[New intervention procedures: lasers, atherectomy, stents].

Schömig A, Seyfarth M, Kastrati A. Schömig A, et al. Among authors: kastrati a. Z Kardiol. 1993;82 Suppl 5:127-31. Z Kardiol. 1993. PMID: 8154151 Review. German.

3

Operator volume and outcome of patients undergoing coronary stent placement.

Kastrati A, Neumann FJ, Schömig A. Kastrati A, et al. J Am Coll Cardiol. 1998 Oct;32(4):970-6. doi: 10.1016/s0735-1097(98)00334-9. J Am Coll Cardiol. 1998. PMID: 9768719 Free article.

4

Long lesions, long stents and the long process of stent optimization.

Schömig A, Kastrati A. Schömig A, et al. Among authors: kastrati a. J Am Coll Cardiol. 1999 Sep;34(3):660-2. doi: 10.1016/s0735-1097(99)00302-2. J Am Coll Cardiol. 1999. PMID: 10483944 Free article. Review. No abstract available.

5

Genetic risk factors and restenosis after percutaneous coronary interventions.

Kastrati A, Dirschinger J, Schömig A. Kastrati A, et al. Herz. 2000 Feb;25(1):34-46. doi: 10.1007/BF03044122. Herz. 2000. PMID: 10713908 Review.

6

Sustained benefit over four years from an initial combined antiplatelet regimen after coronary stent placement in the ISAR trial. Intracoronary Stenting and Antithrombotic Regimen.

Schühlen H, Kastrati A, Pache J, Dirschinger J, Schömig A. Schühlen H, et al. Among authors: kastrati a. Am J Cardiol. 2001 Feb 15;87(4):397-400. doi: 10.1016/s0002-9149(00)01390-4. Am J Cardiol. 2001. PMID: 11179521 Clinical Trial.

7

Good medicines for bad genes.

Kastrati A, Schömig A. Kastrati A, et al. Eur Heart J. 2001 Apr;22(7):523-5. doi: 10.1053/euhj.2000.2448. Eur Heart J. 2001. PMID: 11259136 No abstract available.

8

Images in cardiology: Structural failure of a coronary stent.

Schühlen H, Kastrati A, Schömig A. Schühlen H, et al. Among authors: kastrati a. Heart. 2001 Jul;86(1):26. doi: 10.1136/heart.86.1.26. Heart. 2001. PMID: 11410556 Free PMC article. No abstract available.

9

Incidence of thrombotic occlusion and major adverse cardiac events between two and four weeks after coronary stent placement: analysis of 5,678 patients with a four-week ticlopidine regimen.

Schühlen H, Kastrati A, Pache J, Dirschinger J, Schömig A. Schühlen H, et al. Among authors: kastrati a. J Am Coll Cardiol. 2001 Jun 15;37(8):2066-73. doi: 10.1016/s0735-1097(01)01285-2. J Am Coll Cardiol. 2001. PMID: 11419889 Free article.

10

Stenting for small coronary vessels: a contestable winner.

Kastrati A, Schühlen H, Schömig A. Kastrati A, et al. J Am Coll Cardiol. 2001 Nov 15;38(6):1604-7. doi: 10.1016/s0735-1097(01)01589-3. J Am Coll Cardiol. 2001. PMID: 11704370 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

979 results

Search Page